<div id="readability-page-1"><p>Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CEO Eric P. Lefkofsky sold 562,345 shares of the stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $50.93, for a total transaction of $28,640,230.85. Following the transaction, the chief executive officer now directly owns 9,457,283 shares in the company, valued at $481,659,423.19. This trade represents a 5.61 % decrease in their position. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is accessible through this hyperlink.</p><h2>Tempus AI Stock Up 0.5 %</h2><ul><li>Tempus AI Is a Buy, If You Can Handle the Volatility</li></ul><p>NASDAQ TEM traded up $0.24 during trading hours on Friday, hitting $49.10. 9,329,504 shares of the stock were exchanged, compared to its average volume of 4,780,767. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a 12-month low of $22.89 and a 12-month high of $91.45. The stock has a 50-day moving average of $54.02 and a 200 day moving average of $52.54. </p><h2>Institutional Trading of Tempus AI</h2><p>Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. ARK Investment Management LLC lifted its holdings in shares of  Tempus AI by 355.0% during the 3rd quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company's stock valued at $134,604,000 after acquiring an additional 1,855,459 shares in the last quarter.  Sigma Planning Corp acquired a new stake in shares of  Tempus AI during the third quarter worth approximately $1,323,000.  GSA Capital Partners LLP bought a new position in shares of  Tempus AI in the 3rd quarter worth about $306,000.  Sumitomo Mitsui Trust Group Inc. grew its position in  Tempus AI by 1,591.2% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company's stock worth $68,922,000 after purchasing an additional 1,145,698 shares during the last quarter.  Finally, First Horizon Advisors Inc. bought a new position in shares of  Tempus AI in the third quarter worth $30,000. Hedge funds and other institutional investors own  24.22% of the company's stock. </p><h2>Analyst Ratings Changes</h2><ul><li>Conflicting Signals: Tempus AI's Stock Market Rally </li></ul><p>A number of research firms have issued reports on TEM. Piper Sandler cut their price target on Tempus AI from $70.00 to $55.00 and set a &#34;neutral&#34; rating for the company in a research note on Tuesday. Stifel Nicolaus lowered shares of Tempus AI from a &#34;buy&#34; rating to a &#34;hold&#34; rating and increased their price target for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Needham &amp; Company LLC upped their price target on Tempus AI from $56.00 to $70.00 and gave the company a &#34;buy&#34; rating in a research report on Tuesday, February 25th. Guggenheim  reaffirmed a &#34;buy&#34; rating on shares of Tempus AI in a report on Tuesday, February 25th. Finally, TD Cowen  restated a &#34;buy&#34; rating and set a $74.00 price target (up from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. Six analysts have rated the stock with a hold rating and six have issued  a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of &#34;Moderate Buy&#34; and an average price target of $61.18.</p><p><b>Get Our Latest Analysis on Tempus AI</b></p><h2>About Tempus AI</h2> (Get Free Report)<ul><li>Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound</li></ul><p>Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.</p><h2>See Also</h2><ul><li>Five stocks we like better than Tempus AI</li><li>Health Care Stocks Explained: Why You Might Want to Invest</li><li>Is Myers Industries Poised for a Breakout? </li><li>How to Short Nasdaq: An Easy-to-Follow Guide</li><li>Is BigBear.ai's 25% Plunge a False Alarm or Fire Sale?</li><li>Why Understanding Call Option Volume is Essential to Successful Options Trading</li><li>Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VEVN?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VEVN"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Tempus AI Right Now?</h2><p>Before you consider Tempus AI, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.</p><p>While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Tempus AI, Inc. CEO Eric P. Lefkofsky sold 562,345 shares at an average price of $50.93, totaling approximately $28.64 million, representing a 5.61% decrease in his holdings. He now owns 9,457,283 shares valued at about $481.66 million. The transaction was disclosed to the SEC. Following the sale, Tempus AI's stock rose 0.5% to $49.10. Analysts have mixed ratings on the stock, with an average price target of $61.18, indicating a "Moderate Buy" rating.</p>

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky Sells 562,345 Shares